Mylan Upjohn Merger – Pfizer Shareholders to receive 0.12 Viatris Shares per Pfizer Share

With Pfizer’s Generic business Upjohn and Mylan Merger planned for Q4 of 2020, as an investor you may have some questions in mind, below I have answered couple of the common ones.

Details are gathered by emailing investor relations and using the information on Pfizer and Mylan’s website.

Common Questions –

What will be the name of new company after Mylan and UpJohn Merger ?

Mylan and Pfizer Announced Viatris as the New Company Name.


Viatris Logo

Viatris will have a new ticker symbol and it’s not disclosed yet.

And the stock will trade on NASDAQ which is where Mylan initially traded.

Important Updates

30th June 2020 – Mylan Shareholders approved proposed merger – 99.6% of Shares Voted in Favor.

18th June 2020 – UpJohn announced Pricing of Senior Notes in Connection with the
Proposed merger. A private offering of $7.45 billion aggregate principal amount of Viatris senior, U.S. dollar-denominated notes and €3.60 billion aggregate principal amount of Upjohn Finance (now subsidiary of Viatris) senior, euro-denominated notes.

Viatris Senior Notes - Upjohn Mylan Merger News

Where Viatris stands in Generic Pharma’s business ?

Viatris stands at top in Generic Pharma based on expected sales and market value

Viatris stands at top in Generic Pharma based on expected sales and market value
Source: Investor Presentation – Sept. 2019

Will Pfizer shareholders get Mylan stock ?

Pfizer Shareholders will get Viatris Stock. Ticker symbol not specified yet.

What amount of Viatris Shares will be issued per Pfizer Share ?

For each Pfizer Share you own you will receive 0.12 shares of Viatris.

Or in other words 12 shares per 100 Pfizer Shares.

Calculator to calculate – How many Viatris share you will receive ?

Enter the amount of Pfizer shares you own to know how many Viatris shares you will own.

Your Pfizer Shares:

Example: if you have random number of shares say – 25.55 shares or 8976 shares the calculator will make your life easier.

Management Team

 Viatris Management Team Overview - Investor Presentation

Investor Presentations Summary

Skimming Most Valuable information on the Merger

Merger Summary

Mylan Upjohn merger summary
Source: Investor Presentation August 2020

New Companies Financial Estimates

Viatris Financial Profile
Source: Investor Presentation – July 2019

Pharmaceutical Competitive Landscape

Pharmaceutical Competitive Landscape and where Viatris stands
Source: Investor Presentation – July 2019


Viatris Peers
Source: Investor Presentation August 2020

New Business Modals Execution Plan

Viatris Business Modals Execution Roadmap
Source: Investor Presentation August 2020

Quick Links

Investor Presentations – August 2020

Press Releases

Pfizer and Mylan Announce Two Future Viatris Board Members

About Mylan

Mylan is a global generic pharmaceutical company providing generic healthcare products. Offering a portfolio of over 7,500 marketed products around the world with presense in about 165 countries.


Investor Relations:

About Pfizer Upjohn

With over 130 years of experience, Pfizer Upjohn brings together 20 of the industry’s very recognised brands — products such as Lipitor, Norvasc, Lyrica and Viagra with manufacturing and commercial expertise in more than 120 countries.


Investor Relations:

Default image
Navjot Singh Virk
Navjot is a Hobby Blogger from Ireland and loves to create content to help people. He makes time on weekends to work on this blog. And has a full time position at Verizon Media as Lead Technical Solutions Consultant, which he loves and thrives at. His Skills include in-depth knowledge of SEO, Javascript, Advertising, HTML and Java. And his other hobbies include Investing, Gardening and playing Table Tennis.